Aberrant High Expression of B Lymphocyte Chemokine (BLC/CXCL13) by C11b+CD11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells Towards BLC

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2001 Jun 20

PMID 11413194

Citations 51

Authors

S Ishikawa

T Sato

M Abe

S NAGAI

N Onai

H Yoneyama

Y Zhang

T Suzuki

S Hashimoto

T Shirai

M Lipp

K Matsushima

Affiliations

Soon will be listed here.

Abstract

We observed here that the expression of B lymphocyte chemokine (BLC/CXCL13) was markedly enhanced in the thymus and kidney in aged (NZB x NZW)F1 (BWF1) mice developing lupus nephritis, but not in similarly aged NZB and NZW mice. BLC-positive cells were present in the cellular infiltrates in the target organs with a reticular pattern of staining. CD11b+CD11c+ dendritic cells were increased in the thymus and spleen in aged BWF1 mice and identified as the major cell source for BLC. CD4+ T cells as well as B cells were dramatically increased in the thymus in aged BWF1 mice, whereas no increase was observed in aged NZB and NZW mice. B1/B2 ratio in the thymus was significantly higher than those in the spleen and peripheral blood in aged BWF1 mice. Interestingly, BLC showed preferential chemotactic activity for B1 cells derived from several mouse strains, including nonautoimmune mice. Cell surface CXCR5 expression on B1 cells was significantly higher than that on B2 cells. Thus, aberrant high expression of BLC by myeloid dendritic cells in the target organs in aged BWF1 mice may play a pivotal role in breaking immune tolerance in the thymus and in recruiting autoantibody-producing B cells in the development of murine lupus.

Citing Articles

Altered galectin-3 distribution and migratory function in the pre-diabetic non-obese diabetic mouse thymus.

Ramos T, Ventura A, Lemos J, Chammas R, Savino W, Carvalho-Pinto C Front Endocrinol (Lausanne). 2024; 15:1200935.

PMID: 39483979 PMC: 11524864. DOI: 10.3389/fendo.2024.1200935.

Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort.

Rojas-Rivera J, Hasegawa T, Fernandez-Juarez G, Praga M, Saruta Y, Fernandez-Fernandez B Clin Kidney J. 2024; 17(8):sfae239.

PMID: 39188767 PMC: 11345640. DOI: 10.1093/ckj/sfae239.

Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.

Sato S, Zhang X, Matsuoka N, Sumichika Y, Saito K, Yoshida S Lupus Sci Med. 2023; 10(1).

PMID: 37094946 PMC: 10152041. DOI: 10.1136/lupus-2022-000870.

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases.

Pan Z, Zhu T, Liu Y, Zhang N Front Immunol. 2022; 13:850998.

PMID: 35309354 PMC: 8931035. DOI: 10.3389/fimmu.2022.850998.

Does HTLV-1 Infection Show Phenotypes Found in Sjögren's Syndrome?.

Nakamura H, Tsukamoto M, Nagasawa Y, Kitamura N, Shimizu T, Kawakami A Viruses. 2022; 14(1).

PMID: 35062304 PMC: 8780498. DOI: 10.3390/v14010100.

References

Shu H, Hu W, Johnson H . TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol. 1999; 65(5):680-3. View

Stall A, Lalor P, Sidman C, Moore W, Parks D, Herzenberg L . The Ly-1 B cell lineage. Immunol Rev. 1986; 93:81-102. DOI: 10.1111/j.1600-065x.1986.tb01503.x. View

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

Kotzin B . Systemic lupus erythematosus. Cell. 1996; 85(3):303-6. DOI: 10.1016/s0092-8674(00)81108-3. View

Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer J, Holler N . BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999; 189(11):1747-56. PMC: 2193079. DOI: 10.1084/jem.189.11.1747. View

Mukhopadhyay A, Ni J, Zhai Y, Yu G, Aggarwal B . Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem. 1999; 274(23):15978-81. DOI: 10.1074/jbc.274.23.15978. View

Wortis H, Berland R . Cutting edge commentary: origins of B-1 cells. J Immunol. 2001; 166(4):2163-6. DOI: 10.4049/jimmunol.166.4.2163. View

Pearson C, McDevitt H . Redirecting Th1 and Th2 responses in autoimmune disease. Curr Top Microbiol Immunol. 1999; 238:79-122. DOI: 10.1007/978-3-662-09709-0_5. View

Limmer A, Ohl J, Kurts C, Ljunggren H, Reiss Y, Groettrup M . Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med. 2000; 6(12):1348-54. DOI: 10.1038/82161. View

10.

Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue J, Baggiolini M . BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999; 104(10):R49-54. PMC: 481995. DOI: 10.1172/JCI7830. View

11.

Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y . Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest. 1998; 102(11):1933-41. PMC: 509145. DOI: 10.1172/JCI4619. View

12.

Gross J, Johnston J, Mudri S, Enselman R, Dillon S, Madden K . TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000; 404(6781):995-9. DOI: 10.1038/35010115. View

13.

Baggiolini M . Chemokines and leukocyte traffic. Nature. 1998; 392(6676):565-8. DOI: 10.1038/33340. View

14.

Schaerli P, Willimann K, Lang A, Lipp M, Loetscher P, Moser B . CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med. 2000; 192(11):1553-62. PMC: 2193097. DOI: 10.1084/jem.192.11.1553. View

15.

Gray D, Kosco M, Stockinger B . Novel pathways of antigen presentation for the maintenance of memory. Int Immunol. 1991; 3(2):141-8. DOI: 10.1093/intimm/3.2.141. View

16.

Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H . Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med. 1994; 180(1):111-21. PMC: 2191544. DOI: 10.1084/jem.180.1.111. View

17.

Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H . Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 1992; 357(6373):77-80. DOI: 10.1038/357077a0. View

18.

Moore P, Belvedere O, Orr A, Pieri K, LaFleur D, Feng P . BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999; 285(5425):260-3. DOI: 10.1126/science.285.5425.260. View

19.

Bowman E, Campbell J, Soler D, Dong Z, Manlongat N, Picarella D . Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med. 2000; 191(8):1303-18. PMC: 2193143. DOI: 10.1084/jem.191.8.1303. View

20.

Gunn M, Ngo V, Ansel K, Ekland E, Cyster J, Williams L . A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 1998; 391(6669):799-803. DOI: 10.1038/35876. View